TrumpRx launched in Tennessee. See list of drugs available
Digest more
All 16 drug companies that inked deals with the Trump administration over the past few months still raised some of their prices for 2026.
The latest White House move on drug costs may matter more at the pharmacy than in Washington.
CMS names medications 2028 for Medicare price negotiation, including Trulicity and Biktarvy, targeting high-cost drugs in Parts B and D.
Lower prices from the third round of talks among Medicare and manufacturers will be announced in the fall but won’t go into effect until 2028.